Tenet Healthcare posts strong Q3 2026 results and raises FY2026 outlook

Tenet Healthcare reported third‑quarter 2026 net operating revenue of $5.631 billion, a 6.5% year‑over‑year increase. Adjusted diluted EPS rose to $6.64, up 79.5% from the prior year, and adjusted EBITDA reached $1.355 billion. The company lifted its full‑year 2026 adjusted EBITDA guidance to $5.05 billion‑$5.20 billion and raised its full‑year adjusted EPS guidance to $22.05‑$23.01 per share. Management highlighted strong performance in both the USPI ambulatory segment and hospital segment, while noting an 18% decline in exchange admissions.

The higher FY2026 adjusted EBITDA and EPS guidance suggest stronger profitability and cash generation, which could support continued share repurchases and debt reduction (the company noted $1.615 billion of buybacks YTD). Analysts may view the raised outlook as a catalyst for the stock.

  • 1Net operating revenues were $5.631 billion, a 6.5% increase YoY.
  • 2Adjusted diluted EPS was $6.64, up 79.5% YoY.
  • 3Consolidated adjusted EBITDA was $1.355 billion.
  • 4FY 2026 adjusted EBITDA outlook was raised to $5.05 billion‑$5.20 billion.
  • 5Full‑year 2026 adjusted EPS guidance was raised to $22.05‑$23.01 per share.
  • 6Full‑year 2026 revenue guidance was raised to $22.05 billion‑$22.45 billion.

Sources